BMRN

BioMarin Pharmaceutical
D

BMRN

57.750
USD
0.56
(0.98%)
مغلق
حجم التداول
44,769
الربح لكل سهم
4
العائد الربحي
-
P/E
21
حجم السوق
11,075,044,654
أصول ذات صلة
ALNY
ALNY
-4.39
(-1.33%)
325.26 USD
E
EXEL
1.840
(4.15%)
46.150 USD
GILD
GILD
-0.760
(-0.68%)
110.760 USD
INCY
INCY
0.300
(0.44%)
68.470 USD
I
IONS
-0.450
(-1.03%)
43.190 USD
NBIX
NBIX
-0.380
(-0.29%)
129.040 USD
REGN
REGN
-0.69
(-0.13%)
546.88 USD
R
RGEN
0.490
(0.39%)
127.440 USD
S
SRPT
0.010
(0.06%)
18.200 USD
المزيد
الأخبار المقالات

العنوان: BioMarin Pharmaceutical

القطاع: Healthcare
الصناعة: Biotechnology
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline oftreatments in development.